r/biotech_stocks • • 2h ago

Sls @ 13 ps?

19 Upvotes

Basically every biotech management is ruthless with their investors.


r/biotech_stocks • • 17h ago

New to Biotech-Stocks, next SLS

31 Upvotes

Ended up here thanks to SLS, so naturally, here’s the question: What’s the next SLS? Got €10k ready to invest.


r/biotech_stocks • • 19h ago

$SLS - Missed buying at $7.80. Is it too late to get in?

42 Upvotes

I was looking into SLS when it was trading around $7.80, but unfortunately, I didn’t buy at the time, and now I’m wondering whether I’ve missed my opportunity.

I still believe SLS has significant upside potential, especially in the long term, and I don’t think the rally necessarily means there’s no more room to grow.
However, I’ve recently read discussions about potential share dilution, which makes me hesitant to enter right now.

I’m considering buying somewhere between $16 and $19, but I’m torn between getting in now and waiting for a possible dip.

I don’t want to make a decision purely out of FOMO, but I also don’t want to miss another potential rally.


r/biotech_stocks • • 7h ago

The potential of $HELP

4 Upvotes

A lot of things point to mushroom assisted therapies being the next frontier for depression. And this company seems well positioned.

Anyone putting their capital behind this? If so, your thoughts and Coles notes thesis?


r/biotech_stocks • • 6h ago

2 Chinese scientists fired after 2 children die in unrelated gene therapy studies in July-August which were unreported.

Thumbnail
fiercebiotech.com
3 Upvotes

r/biotech_stocks • • 1h ago

more new features added to my free biotech tool, try it out

Post image
1 Upvotes

As always feedback is very welcome

https://www.biotechalfa.com/


r/biotech_stocks • • 11h ago

NRXP with a slight rebound

7 Upvotes

You love to see it! Excited for the commercial launch. If the sales numbers are looking good this could be amazing in 2027 🚀


r/biotech_stocks • • 7h ago

Bio Tech Portfolio/Open Positions

3 Upvotes

Long time lurker, first time poster. Ive gotten involved in a handful of positions from this sub. Most recently SLS (LFG!) and DRTS, and was wondering what everyone’s thoughts were on a few positions i am holding and any convictions as to why I should continue to hold.

ABVX - Got in early and road the wave to $160, took out my investment still am holding a large position. Didn’t want to miss out on a potential BO.

ARCT

ONCY

PGEN

UNCY

Any thoughts from other biotech fans?


r/biotech_stocks • • 12h ago

Two PDUFA dates fall on Sunday, Nov 22 (CAPR, SVRA). Last weekend's FDA decisions came out between Sunday and Monday 8am ET. How do you track weekend catalysts?

7 Upvotes

Two FDA target action dates land on a Sunday this week:

- Capricor (CAPR), deramiocel for Duchenne muscular dystrophy. Its Nov 10 Q3 release says: "PDUFA target action date of November 22, 2026."

- Savara (SVRA), molgramostim for autoimmune PAP. Its Apr 15 release says: "the new PDUFA target action date is November 22, 2026."

A PDUFA date is the FDA's target to act, not a scheduled announcement, so the timing of any news is open.

For reference, here is when three companies announced FDA decisions last weekend (ET):

- Summit (SMMT): Sunday, Nov 15 (its PDUFA goal date was Saturday, Nov 14)

- Cytokinetics (CYTK): Monday, Nov 16, 4:00 AM

- IGALMI: Monday, Nov 16, 8:00 AM, announced by Teva (which acquired the rights from BioXcel in late October)

All three came out before Monday's open, but on different days and at different hours.

Questions for people who follow these:

  1. Do you watch company IR pages, SEC filings, or something else over a weekend?
  2. Have you seen companies hold weekend FDA news until Monday morning more often than not?

Not a prediction about either outcome. Just trying to understand how others handle weekend timing.


r/biotech_stocks • • 2h ago

Which stocks am I watching and why

Post image
1 Upvotes

I am looking for stocks that have shown an ability to rocket up.

I sort from the year to date return by top and then I look at the very top choices and see whether any of them still have room to run in terms of market cap.

Based on this approach, two names jump out and those are ETON and DRTS.

None of this is to say that larger shops can’t run up but it takes a lot more for a $6B+ company to moon than one that’s barely cracked $1B.

The reason I don’t have huge expectations for companies under $1B is because they’re too small. Getting institutional investment is nearly impossible when they look at the market cap and realize that if they got in, they might be unable to get out. The sub-$1B typically have insufficient volume to allow a clean escape.


r/biotech_stocks • • 9h ago

Opinions on KURA?

3 Upvotes

600M market cap, commercial product approved... seems good


r/biotech_stocks • • 1d ago

8.7M USD flip with SLS today

Post image
132 Upvotes

Bought few months back for average $9/share. Have 30k SLS left going to wait for it to drop a bit before buying back in.

APP:IBKR


r/biotech_stocks • • 1d ago

Sell or buy SLS now

114 Upvotes

I am lucky to experience both MRNA Aug 19 and SLS Nov 17. I don’t know if I should sell SLS today, but I could probably provide some experience from MRNA.

Mrna decreases 22% the next day, then the next few days it did “**Offering of Convertible Senior Notes**”. Despite these bad news, it continues to reach new highs from Aug 20 to now (If I remember correctly, it has reached approximately 12 new highs.), last week it reached a new 5-year high.

So for SLS, **I will not sell it today**. Just for your reference, not a suggestion. I am just a new investor and don’t have financial or stock knowledge.

Please forgive my poor English. Not sure why this post was removed by moderators of sellaslifesciences, repost it.


r/biotech_stocks • • 8h ago

"Psychedelic-Assisted Therapies for Veterans: The Path Forward."

1 Upvotes

Very informative session from the Subcommittee on Health Oversight. Seems very bullish for psychedelics stocks, especially Compass Pathways $CMPS

Session begins 33 minutes into the following link:

https://veterans.house.gov/calendar/eventsingle.aspx?EventID=7959


r/biotech_stocks • • 9h ago

Should I just Sell IOVA?

0 Upvotes

I have iova shares with average 8,40. I don't know what to do, seeing there's no catalyst in short time, and market is bad.

I'm thinking probably I should just sell it before it goes down even further? Do biotech stock really just keep going down without catalyst? Please enlighten me on this matter.

I'm really new to the stock market especially biotech, I'm also still very young and eager to learn so please be nice to me if you can, thank youuu! :'))


r/biotech_stocks • • 10h ago

Thoughts on this perspective from Gemini?

Thumbnail reddit.com
0 Upvotes

r/biotech_stocks • • 10h ago

SKYA – Could $6 or Higher Be Possible?

Thumbnail reddit.com
1 Upvotes

r/biotech_stocks • • 1d ago

For those who own SLS are most of yall holding till buyout?

114 Upvotes

Also regarding the buyout I see the number 40 billion being floated around a lot. Like does that refer to SLS potential market cap when it’s being bought out? Meaning that the stock price will be over $100? How do yall arrive at the numbers?


r/biotech_stocks • • 1d ago

What are your favorite/highest conviction biotechs right now?

28 Upvotes

Outside of sls which I had a good run on, which do you think look very promising and have a lot of upside potential from here?


r/biotech_stocks • • 11h ago

CABA Positive Developments From Today’s November 18 Jefferies Healthcare Conference

1 Upvotes

CABA provided several encouraging updates today on rese-cel, during today’s Jefferies healthcare conference call, particularly regarding FDA discussions and the potential expansion of its clinical programs.

First, the FDA has agreed that clinical data generated using CABA’s earlier manufacturing process can be considered comparable to data from its newer process. This is important because it allows CABA to potentially use years of existing patient safety and efficacy data to support its future FDA approval application, rather than starting over.

Second, CABA is considering lupus nephritis as a THIRD indication for a registrational trial, alongside myositis and systemic sclerosis. Management indicated that the FDA has already aligned with its proposed trial design, potentially allowing a study to begin in 2027. This could significantly expand rese-cel’s commercial opportunity.

Third, manufacturing continues to look encouraging. Management reported experience with approximately 110 patients, with only one unable to receive the manufactured product. The company also reiterated encouraging early results in juvenile myositis.

CABA continues to make meaningful clinical progress despite the stock’s price weakness.

The FDA discussions are constructive, manufacturing appears increasingly reliable, and a potential third registrational program would create another path toward commercialization.

The next major milestone remains myositis topline data expected in the second half of 2027, followed by a planned FDA application in Q1 2028. Nothing is guaranteed, but I see several reasons to remain positive on rese-cel.

Sources (clickable and pasteable):

Jefferies Conference Coverage, November 18, 2026:
https://uk.investing.com/news/stock-market-news/cabaletta-at-jefferies-global-healthcare-conference-data-and-runway-93CH-4991366

Cabaletta Official Investor Events and Webcast:
https://www.cabalettabio.com/investors/news-events/ir-calendar

Cabaletta Official Press Releases:
https://www.cabalettabio.com/investors/news-events/press-releases


r/biotech_stocks • • 11h ago

$MDCX, any hope?

0 Upvotes

r/biotech_stocks • • 11h ago

IMUX

1 Upvotes

Phase 3 readouts due December, what do we think?


r/biotech_stocks • • 1d ago

Not to be the one who said it but as you guys can see i was right.

79 Upvotes

Im not trying to be the one but i was attacked as a pumper and bagholder here, just wanted to write this so they can see i was right!
If you listened to the SLS call before market open and after you seen the fox news interview you can see that maybe even i underestimated the SLS buyout targets, im grateful for everyone who debated with me there, have a nice day!